Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
Enterprise Therapeutics (Enterprise) has successfully administered ETD001 to an individual with Cystic Fibrosis. The biopharmaceutical company is focused on developing therapies to help improve the lives of those suffering from respiratory disease. Today’s …